We are live on
!
Find out more
MBE
Michael B. Elefante Portfolio holdings
AUM
$91.5M
Turnover
27.89%
1-Year Est. Return
13.24%
This Fund
S&P 500
This Quarter
Est. Return
+1.4%
1 Year Est. Return
+13.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$184M
AUM Growth
–
Cap. Flow
+$185M
Cap. Flow
% of AUM
100.56%
Top 10 Holdings %
Top 10 Hldgs %
35.73%
Holding
108
New
108
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$7.69M |
| 2 |
CVS Health
CVS
|
+$7.64M |
| 3 |
Emerson Electric
EMR
|
+$6.95M |
| 4 |
Novartis
NVS
|
+$6.93M |
| 5 |
Procter & Gamble
PG
|
+$6.82M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 25.97% |
| 2 | Technology | 20.49% |
| 3 | Industrials | 17.98% |
| 4 | Energy | 10.31% |
| 5 | Consumer Staples | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Tortoise Energy Infrastructure Corp
TYG
$989M
| $256K | 0.14% |
+1,375
| New | +$251K |
2013 Q2
0 quarters
|
|
77
Wolfspeed
WOLF
$1.3B
| $249K | 0.14% |
+3,900
| New | +$228K |
2013 Q2
0 quarters
|
|
|
HMSY
78
DELISTED
HMS Holdings Corp.
HMSY
| $248K | 0.13% |
+10,635
| New | +$263K |
2013 Q2
0 quarters
|
|
79
T. Rowe Price
TROW
$21.3B
| $245K | 0.13% |
+3,345
| New | +$250K |
2013 Q2
0 quarters
|
|
80
Dominion Energy
D
$55.2B
| $242K | 0.13% |
+4,260
| New | +$250K |
2013 Q2
0 quarters
|
|
|
MON
81
DELISTED
Monsanto Co
MON
| $239K | 0.13% |
+2,425
| New | +$254K |
2013 Q2
0 quarters
|
|
82
Jacobs Solutions
J
$16.6B
| $236K | 0.13% |
+5,180
| New | +$230K |
2013 Q2
0 quarters
|
|
|
TWC
83
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $236K | 0.13% |
+2,100
| New | +$203K |
2013 Q2
0 quarters
|
|
|
QEP
84
DELISTED
QEP RESOURCES, INC.
QEP
| $217K | 0.12% |
+7,816
| New | +$227K |
2013 Q2
0 quarters
|
|
85
NextEra Energy
NEE
$163B
| $216K | 0.12% |
+10,600
| New | +$210K |
2013 Q2
0 quarters
|
|
86
AT&T
T
$158B
| $215K | 0.12% |
+8,042
| New | +$223K |
2013 Q2
0 quarters
|
|
87
Healthpeak Properties
DOC
$12.9B
| $213K | 0.12% |
+5,169
| New | +$236K |
2013 Q2
0 quarters
|
|
88
Cognizant
CTSH
$28.1B
| $209K | 0.11% |
+6,660
| New | +$221K |
2013 Q2
0 quarters
|
|
|
COL
89
DELISTED
Rockwell Collins
COL
| $206K | 0.11% |
+3,245
| New | +$207K |
2013 Q2
0 quarters
|
|
90
Ovintiv
OVV
$18.5B
| $202K | 0.11% |
+2,382
| New | +$221K |
2013 Q2
0 quarters
|
|
91
Pfizer
PFE
$166B
| $202K | 0.11% |
+7,585
| New | +$210K |
2013 Q2
0 quarters
|
|
92
US Bancorp
USB
$87.7B
| $188K | 0.1% |
+5,195
| New | +$178K |
2013 Q2
0 quarters
|
|
93
AES
AES
$10.7B
| $169K | 0.09% |
+14,100
| New | +$179K |
2013 Q2
0 quarters
|
|
94
Aflac
AFL
$59.3B
| $160K | 0.09% |
+5,500
| New | +$149K |
2013 Q2
0 quarters
|
|
95
Union Pacific
UNP
$170B
| $134K | 0.07% |
+1,740
| New | +$131K |
2013 Q2
0 quarters
|
|
96
DELISTED
Praxair Inc
PX
| $93K | 0.05% |
+810
| New | +$92.3K |
2013 Q2
0 quarters
|
|
97
Vodafone
VOD
$35.9B
| $72K | 0.04% |
+2,443
| New | +$72.9K |
2013 Q2
0 quarters
|
|
98
Danaher
DHR
$158B
| $8K | ﹤0.01% |
+179
| New | +$7.41K |
2013 Q2
0 quarters
|
|
99
JPMorgan Chase
JPM
$890B
| $4K | ﹤0.01% |
+76
| New | +$3.86K |
2013 Q2
0 quarters
|
|
Similar funds
AEPI
CC
TM
VNB
ECP
WIL
RCM
ZTNA
Michael B. Elefante's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Michael B. Elefante, which disclosed 108 positions worth $184M. Its ten largest holdings account for 36% of the portfolio.
Its largest position is Johnson & Johnson: 90,570 shares worth $7.78M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, followed by Technology and Industrials.
- Michael B. Elefante's largest Q2 2013 buy was Johnson & Johnson: 90,570 shares worth $7.78M.
- Michael B. Elefante's ten largest holdings make up 36% of its $184M portfolio in Q2 2013.
- Michael B. Elefante disclosed 108 positions in Q2 2013, its first 13F filing on record.
Based on Michael B. Elefante's 13F filing for Q2 2013, filed 19 Aug 2013.